Page last updated: 2024-11-05

nopinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Nopinone is a bicyclic ketone derived from α-pinene. It is a chiral molecule, and its enantiomers exhibit different biological activities. Nopinone is known for its antimicrobial, insecticidal, and anti-inflammatory properties. It has been studied for its potential applications in pharmaceutical and agricultural industries. Nopinone can be synthesized from α-pinene through a series of reactions involving oxidation and rearrangement. The unique structure and biological activity of nopinone make it an interesting target for research and development.'

nopinone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID32735
CHEBI ID181453
SCHEMBL ID720591
MeSH IDM0452883

Synonyms (31)

Synonym
LS-13665
CHEBI:181453
.beta.-pinone
24903-95-5
nopinon
nopinone
nsc135004
nsc-135004
bicyclo[3.1.1]heptan-2-one,6-dimethyl-
2-norpinanone,6-dimethyl-
6,6-dimethylbicyclo[3.1.1]heptan-2-one
(1r)-(+)-norinone
bicyclo[3.1.1]heptan-2-one, 6,6-dimethyl-
nsc250997
(1r)-6,6-dimethyldicyclo[3.1.1]heptan-2-one
AKOS004907716
bicyclo(3.1.1)heptan-2-one, 6,6-dimethyl-
2-norpinanone, 6,6-dimethyl-
nsc 135004
6,6-dimethylbicyclo(3.1.1)heptan-2-one
einecs 246-520-3
beta-pinone
FT-0639485
SCHEMBL720591
6,6-dimethyl-bicyclo[3.1.1]heptan-2-one
CS-0101275
DTXSID20865173
SY211609
A936770
SB45077
EN300-182727
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monoterpenoidAny terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's3 (42.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.72 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]